Sold as Colbenemid. Every FDA application for this active ingredient: 1 branded and 10 generic.
As of Nov 15, 2026, FDA lists 11 applications for Colchicine; Probenecid (sold as Colbenemid), first approved Jul 27, 1961, with 0 new uses approved and 0 published complete response letters.
| Jul 27, 1961 | ColbenemidNDA 12383 · New combination | Merck | 13 | Discontinued |
| Apr 7, 1975 | Probenecid W/ ColchicineANDA 83221 | Watson Labs | 0 | Discontinued |
| Mar 11, 1976 | Probenecid And ColchicineANDA 84321 | Beecham | 0 | Discontinued |
| Nov 23, 1976 | Col-ProbenecidANDA 84279 | Watson Labs | 17 | Marketed |
| Sep 15, 1977 | Proben-CANDA 85552 | Watson Labs | 0 | Discontinued |
| Jun 12, 1978 | Probenecid And ColchicineANDA 83734 | Ani Pharms | 18 | Discontinued |
| Sep 6, 1979 | Probenecid W/ ColchicineANDA 86954 | Lederle | 1 | Discontinued |
| Mar 18, 1980 | Probenecid And ColchicineANDA 86130 | Sandoz | 0 | Discontinued |
| May 13, 2008 | Probenecid And ColchicineANDA 40618 | Ingenus Pharms LLC | 0 | Marketed |
| Oct 24, 2023 | Probenecid And ColchicineANDA 217030 | Rising | 0 | Marketed |
| — | Probenecid And ColchicineANDA 83720 | Impax Labs | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Sandoz
Impax Labs